The effectiveness and safety of posterior scleral reinforcement with vitrectomy for myopic foveoschisis treatment: A systematic review and meta-analysis
Graefe's Archive for Clinical and Experimental Ophthalmology Dec 16, 2019
Cao K, Wang J, Zhang J, et al. - Experts included 14 studies (311 eyes) for a systematic review and meta-analysis to examine the efficiency and safety of posterior scleral reinforcement (PSR) combined with vitrectomy for myopic foveoschisis (MF) treatment. They found the pooled complication rate was 9%. Analysis indicated that PSR combined with vitrectomy enhance 80% MF people best-corrected visual acuity with the average benefit of − 0.46 logMAR unit. Individuals with AL ≥ 30 mm profited more in comparison to people with AL < 30 mm with the average variance in AL of − 1.74 mm. They discovered that the retinal reattachment rate is up to 93% and the macular hole (MH) closure rate is 65%. Nearly 9% of people would suffer from extrusion, choroidal atrophy, choroidal neovascularization, and other complications. Moreover, the results were not affected by the presence of MH, illness recurrence, or ILM peeling.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries